Figure 7.
Lymphoid reconstitution after neonatal treatment. (A) Number of mature T and B cells in the peripheral circulation of GT (–/– GT) and transplant-recipient ADA–/– mice (–/– BMT) treated at neonatal age. As control, untreated age-matched ADA+/+ mice (+/+; n = 6) are reported. FACS analysis was used to determine the absolute number, represented as mean ± SD, of white blood cells, CD3+CD4+ and CD3+CD8+ T cells, B220+IgM+ B cells, and NK cells evaluated 5 months after GT (n = 5) or BMT (n = 8). Cell counts from untreated 18-day-old ADA–/– (–/–; n = 14) and ADA+/+ (+/+; n = 8) mice are shown on the right. (B) H&E stainings of thymus and spleen sections (× 5 magnification) in ADA–/– mice (untreated, treated with GT or BMT) and ADA+/+ mice. Tissues from ADA–/– untreated controls were collected postnatally at day 18, while all other mice were analyzed 6 months after treatment.

Lymphoid reconstitution after neonatal treatment. (A) Number of mature T and B cells in the peripheral circulation of GT (–/– GT) and transplant-recipient ADA–/– mice (–/– BMT) treated at neonatal age. As control, untreated age-matched ADA+/+ mice (+/+; n = 6) are reported. FACS analysis was used to determine the absolute number, represented as mean ± SD, of white blood cells, CD3+CD4+ and CD3+CD8+ T cells, B220+IgM+ B cells, and NK cells evaluated 5 months after GT (n = 5) or BMT (n = 8). Cell counts from untreated 18-day-old ADA–/– (–/–; n = 14) and ADA+/+ (+/+; n = 8) mice are shown on the right. (B) H&E stainings of thymus and spleen sections (× 5 magnification) in ADA–/– mice (untreated, treated with GT or BMT) and ADA+/+ mice. Tissues from ADA–/– untreated controls were collected postnatally at day 18, while all other mice were analyzed 6 months after treatment.

Close Modal

or Create an Account

Close Modal
Close Modal